Build status - In Progress

Does vaginal delivery of combined hormonal contraception affect the risk of metabolic syndrome in overweight/obese women with PCOS?

Recruiting
99 years or below
All
40 participants needed
1 Location

Brief description of study

This research study is being conducted to determine if there is an effect on the development of Metabolic Syndrome (MetS) in women with PCOS when using NuvaRing. This study will recruit 40 women between the ages of 18-40, with a diagnosis of PCOS, NO diagnosis of MetS, and a BMI between 25 and 45. Women will be asked to use NuvaRing for 4 months. They will have fasting bloodwork (including OGTT) at baseline and four months, and will be contacted once a month by research staff.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Polycystic Ovary Syndrome, PCOS
  • Age: 99 years or below
  • Gender: All
Updated on 04 Aug 2024. Study ID: 834422

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center